Cube Labs S.P.A. (IT:CUBE) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cube Labs’ subsidiary, Adamas Biotech, has secured official registration from Italy’s Ministry of Health for Theakine® Prost, a green tea-based supplement aimed at improving prostate health. The company plans to partner with firms in the urology sector for its distribution, rather than marketing it directly. This development signifies a strategic advancement in Cube Labs’ commercial endeavors within the healthcare sector.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.